Day: March 26, 2020

NORWALK, Conn., March 26, 2020 (GLOBE NEWSWIRE) — FactSet (“FactSet” or the “Company”) (NYSE:FDS) (NASDAQ:FDS), a global provider of integrated financial information, analytical applications, and industry-leading service, today announced results for its second quarter ended February 29, 2020.Second Quarter Fiscal 2020 HighlightsRevenue increased 4.2%, or $14.9 million, to $369.8 million compared with $354.9 million for the same period in fiscal 2019. The increase is primarily due to higher sales of analytics, wealth management solutions, and content and technology solutions (CTS). Organic revenues grew 4.2% to $371.0 million during the second quarter of fiscal 2020 from the prior year period.Annual Subscription Value (ASV) plus professional services was $1.50 billion at February 29, 2020, compared with $1.44 billion...

VANCOUVER, British Columbia, March 26, 2020 (GLOBE NEWSWIRE) — Aldebaran Resources Inc. (“Aldebaran” or the “Company”, ALDE TSX.V) is providing an update on site activities at its Altar copper-gold project in Argentina and the Company’s response to the ongoing COVID-19 pandemic.The Company’s current priority in the face of the COVID-19 pandemic is to ensure that all employees and their families are safe and minimize any potential risks to them or others in the communities where we live and work. On March 19, 2020, the Argentinian government declared mandatory quarantine until the end of March and the Company immediately arranged for the field-camp to be closed and all its employees and contractors to return home. Aldebaran employees in Argentina will now remain at home until the government mandated quarantine...

OTTAWA, March 26, 2020 (GLOBE NEWSWIRE) — Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX-V:TBP) (OTCQB:TBPMF), a leader in cannabinoid-derived drug discovery and development, today announced the results of a survey conducted among US and Canadian patients and physicians which validated the primary endpoint of the SERENITY© pivotal trial. The results confirm that the primary endpoint in the SERENITY© clinical trial is accurateAbout Cancer Cachexia Fifty to 80% of cancer patients experience cachexia during their disease1 Cachexia is defined as “multifactorial syndrome characterized by an ongoing loss of skeletal muscle mass (with or without loss of fat mass) that cannot be fully reversed by conventional nutritional support and leads to progressive functional impairment”2. The most intense symptoms reported by the cachectic...

BARRIE, Ontario, March 26, 2020 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce the launch of its new family of “MediPharm Labs” branded products to deliver high quality, innovative offerings to consumers in the medical and adult-use markets across Canada. With its sophisticated, pharmaceutical-quality GMP certified platform and R&D capabilities, MediPharm Labs has the ability to create best-in-class products, with the formulations, potency and purity to meet current needs and evolving consumer trends.  MediPharm Labs new line of medical and wellness products are targeted for distribution across multiple patient...

SAINT LAURENT, Quebec, March 26, 2020 (GLOBE NEWSWIRE) — IntelGenx Technologies Corp. (TSX V:IGX)(OTCQX:IGXT) (the “Company” or “IntelGenx”) today reported financial results for the fourth quarter and twelve-month periods ended December 31, 2019. All dollar amounts are expressed in U.S. currency, unless otherwise indicated, and results are reported in accordance with United States generally accepted accounting principles except where noted otherwise.2019 Fourth Quarter Financial Highlights:Revenue was $68,000, compared to $651,000 in the 2018 fourth quarterAdjusted EBITDA was ($2.1 million), compared to ($2.0 million) in Q4-20182019 Full-Year Financial Highlights:Revenue was $742,000, compared to $1.8 million in 2018Net comprehensive loss was $10.3 million, compared to net comprehensive loss of $10.6 million...

Dosing Initiated in PROPEL Phase 1/2 Trial of PR001 for Treatment of Parkinson’s Disease with GBA1 MutationsPreparations Underway to Initiate PROVIDE Phase 1/2 Trial of PR001 for Treatment of Type 2 Neuronopathic Gaucher Disease in Mid-2020IND for PR006 for Treatment of Patients with Frontotemporal Dementia with GRN Mutation Active; Initiation of PROCLAIM Phase 1/2 Trial Planned for Mid-2020Cash Runway into First Half of 2022NEW YORK, March 26, 2020 (GLOBE NEWSWIRE) — Prevail Therapeutics Inc. (Nasdaq: PRVL), a biotechnology company developing potentially disease-modifying AAV-based gene therapies for patients with neurodegenerative diseases, today reported financial results for the full year ended December 31, 2019, and reviewed recent business highlights.“2019 was an important year for Prevail as we continued to make important...

MONTRÉAL, March 26, 2020 (GLOBE NEWSWIRE) — Saputo Inc. (TSX:SAP) – A conference call for analysts and institutional investors will be held on Thursday, March 26, 2020, at 11:00 a.m. (Eastern Time), to discuss the COVID-19 situation.The conference call will begin with a short presentation followed by a question and answer period. The speakers will be Mr. Lino Saputo, Jr., Chair of the Board and Chief Executive Officer, Mr. Maxime Therrien, Chief Financial Officer and Secretary, and Mr. Kai Bockmann, President and Chief Operating Officer, Saputo Inc. and International Sector.To participate in the conference: 1-800-954-0688Please dial-in approximately ten minutes before the call.To listen to the call on the Web: http://www.gowebcasting.com/10559  Replay of the conferenceA replay of the conference call will be available until Thursday,...

MONTRÉAL, 26 mars 2020 (GLOBE NEWSWIRE) — Saputo inc. (TSX : SAP) – Une conférence téléphonique pour les analystes et les investisseurs institutionnels, traitant de la situation du COVID-19, aura lieu le jeudi 26 mars 2020, à 11 h 00 (heure de l’Est).La conférence débutera par une courte présentation, suivie d’une période de questions. Les conférenciers seront M. Lino Saputo, Jr., président du conseil d’administration et chef de la direction, M. Maxime Therrien, chef de la direction financière et secrétaire et M. Kai Bockmann, président et chef de l’exploitation, Saputo inc. et Secteur InternationalPour participer à la conférence : 1-800-954-0688Veuillez SVP signaler ce numéro dix minutes avant le début de la conférence.Pour écouter cet appel sur le Web : http://www.gowebcasting.com/10560   Enregistrement différé de la conférenceUn...

MONTRÉAL, March 26, 2020 (GLOBE NEWSWIRE) — Saputo Inc. (TSX:SAP) – A conference call for analysts and institutional investors will be held on Thursday, March 26, 2020, at 11:00 a.m. (Eastern Time), to discuss the COVID-19 situation.The conference call will begin with a short presentation followed by a question and answer period. The speakers will be Mr. Lino Saputo, Jr., Chair of the Board and Chief Executive Officer, Mr. Maxime Therrien, Chief Financial Officer and Secretary, and Mr. Kai Bockmann, President and Chief Operating Officer, Saputo Inc. and International Sector.To participate in the conference: 1-800-954-0688Please dial-in approximately ten minutes before the call.To listen to the call on the Web: http://www.gowebcasting.com/10559  Replay of the conferenceA replay of the conference call will be available until Thursday,...

Assemblée générale mixte du 1er avril 2020Paris, le 26 mars 2020, à 12hGroupe Partouche précise ce jour que, dans le cadre des restrictions de circulation et des mesures de confinement imposées par le gouvernement, son Assemblée générale mixte se tiendra exceptionnellement à huis clos le mercredi 1er avril 2020 à 10h au siège de la société, 141 bis rue de Saussure, 75017 Paris, hors la présence des actionnaires.Fondé en 1973, le Groupe Partouche a su se développer afin de devenir un leader européen dans son secteur d’activité. Coté en Bourse, il exploite des casinos, des hôtels, des restaurants, des centres thermaux et des golfs. Le Groupe exploite 42 casinos et emploie plus de 4 200 collaborateurs. Il est reconnu pour ses innovations et ses expérimentations des jeux de demain, ce qui lui permet d’aborder l’avenir avec...